Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: An update anno 2000

Pathologie Biologie

Volumn 49, Issue 2, 2001, Pages 148-152

  Cervantes, F ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Myelofibrosis; Myeloid metaplasia; Prognostic factor; Therapeutic strategy

Indexed keywords

ANDROGEN; HEMOGLOBIN; HYDROXYUREA;

ADULT; AGED; ANEMIA; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PALLIATIVE THERAPY; PROGNOSIS; SCORING SYSTEM; SPLENECTOMY;

EID: 0035088110     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(00)00020-1     Document Type: Conference Paper

References (28)

1. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferatîve syndrome
2. The syndrome of idiopathic myelofibrosis: A clinicopathologic review with emphasis on the prognostic variables predicting survival
3. Anaemia in myelofibrosis: Its value in prognosis
4. A prognostic classification of myelofibrosis with myeloid metaplasia
5. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases
6. Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients
7. Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system
8. Idiopathic primary osteo-myelofibrosis: A clinicopathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact
9. Identification of "short-lived" and "long-lived" patients at presentation of idiopathic myelofibrosis
10. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases
11. Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk-groups
12. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European Group for Blood and Marrow Transplantation
13. Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival
14. Reversal of myelofibrosis by hydroxyurea
15. Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: The value of chromosomal studies in predicting response and survival
16. Treatment of agnogeneic myeloid metaplasia with danazol: A report of four cases
17. Liver dysfunction following splenectomy in idiopathic myelofibrosis: A study of 10 patients
18. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia
19. Spinal cord compression due to extramedullary hematopoiesis. Successful treatment in a patient with long-standing myelofibrosis
20. Idiopathic myelofibrosis: Pathogenesis, natural history and management
21. 3 in control of BM collagen deposition
22. The role of alfa-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): A concise update
23. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach
24. Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia
25. Suramin toxicity and efficacy in agnogenic myeloid metaplasia
26. 2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia
27. Cyclosporin-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: A preliminary report
28. Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative states